ASU researcher’s microscale tech is chipping away at cancer, organ failure and neurological disease
Pioneering work in organ-on-a-chip technologies and related to contributions to engineering of biomimetic tissue-on-chip technologies and organoids for disease modeling and regenerative medicine are among accomplishments that have recently earned Mehdi Nikkah membership in the American Institute for Medical and Biomedical Engineering College of Fellows. The associate professor in the School of Biological Health Systems Engineering, part of the Fulton Schools, is currently expanding his work through efforts to make microchip technologies more accessible to the scientific and pharmaceutical communities for enhanced drug testing and accurate disease modeling.